| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.6B | $26.8B | $26.9B | $27.0B | $25.8B | $20.4B | $21.3B | $21.4B |
| Cost of Revenue | $22.7B | $22.0B | $21.8B | $21.7B | $20.9B | $16.8B | $17.8B | $18.0B |
| Gross Profit | $4.9B | $4.8B | $5.1B | $5.3B | $5.0B | $3.6B | $3.5B | $3.4B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.4B | $3.3B | $3.3B | $3.0B | $2.9B | $2.4B | $2.6B | $2.5B |
| Operating Income | $1.2B | $1.3B | $1.7B | $2.0B | $1.9B | $0.6B | $0.8B | $0.8B |
| Net Income | $0.6B | $0.7B | $1.0B | $1.4B | $1.4B | $0.4B | $0.5B | $0.4B |
| EPS (Basic) | $17.26 | $17.09 | $22.89 | $24.47 | $18.50 | $4.32 | $4.99 | $4.36 |
| EPS (Diluted) | $17.04 | $16.92 | $22.74 | $24.29 | $18.31 | $4.30 | $4.97 | $4.34 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.4B | $13.0B | $12.0B | $10.1B | $8.9B | $9.9B | $10.5B | $10.7B |
| Current Assets | $4.6B | $4.7B | $4.3B | $3.1B | $2.8B | $4.2B | $4.4B | $4.9B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.6B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.5B | $6.3B | $5.6B | $3.4B | $3.1B | $4.2B | $5.1B | $5.7B |
| Stockholders' Equity | $2.3B | $2.5B | $2.2B | $2.0B | $2.4B | $3.2B | $3.2B | $2.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.3B | $0.7B | $1.7B | $1.6B | $1.2B | $0.8B | $0.5B |
| Investing Cash Flow | $-0.7B | $0.0B | $-0.6B | $-0.5B | $-0.5B | $-0.1B | $-0.1B | $-0.3B |
| Capital Expenditures | $0.3B | $0.3B | $0.4B | $0.3B | $0.2B | $0.2B | $0.3B | $0.4B |
| Financing Cash Flow | $0.6B | $-0.3B | $-0.2B | $-1.2B | $-1.7B | $-0.6B | $-0.7B | $-0.2B |